Bristol-Myers Squibb

BMYleader

Bristol-Myers Squibb is a global biopharmaceutical company with leading franchises in oncology and cardiovascular medicine. Eliquis is the world's best-selling oral anticoagulant and Opdivo is a top-selling cancer immunotherapy.

⇄ Compare

Products & Revenue

Product Revenue Share

Revenue Breakdown ($45.0B)

Static data (loading live financials…)

Oncology (42%)

Cardiovascular (33%)

Immunology (15%)

Other (10%)

Segment Breakdown & Key Customers

Product Details

Eliquis30%

Blood thinner for stroke prevention in atrial fibrillation

Opdivo25%

Immuno-oncology checkpoint inhibitor for multiple cancer types

Revlimid15%

Treatment for multiple myeloma and other blood cancers

Other Specialty30%

Cardiovascular, immunology, and fibrosis therapeutics pipeline

Supply Chain Relationships

Competitors

Johnson & Johnson

Oncology, immunology drugs

Impact: Major pharma competitor

Key Customers

UnitedHealth Group

Formulary drug placements

Impact: $3B+ annually

The Cigna Group

Drug coverage via Express Scripts

Impact: $2B+ annually

Macro & Market Context

헬스케어Sector News

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Upcoming Catalysts

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Latest News

Loading news...

AI Analysis

Click "Get AI Analysis" for an AI-powered supply chain analysis of Bristol-Myers Squibb.

Company Info

Headquarters

New York, New York, USA

Founded

1887

Employees

34,000+

Website

bms.com

Sector Overview — 헬스케어

Sector News